Bryan M. Wittmann

1.7k total citations
26 papers, 1.2k citations indexed

About

Bryan M. Wittmann is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bryan M. Wittmann has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bryan M. Wittmann's work include Metabolomics and Mass Spectrometry Studies (9 papers), Estrogen and related hormone effects (8 papers) and Prostate Cancer Treatment and Research (5 papers). Bryan M. Wittmann is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Estrogen and related hormone effects (8 papers) and Prostate Cancer Treatment and Research (5 papers). Bryan M. Wittmann collaborates with scholars based in United States, Germany and Slovenia. Bryan M. Wittmann's co-authors include Donald P. McDonnell, Monica M. Montano, Andrea B. Sherk, John D. Norris, James D. Joseph, Huaxia Cui, Ching‐yi Chang, Yair Lotan, Bruce Neri and Daju Fan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Bryan M. Wittmann

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan M. Wittmann United States	18	763	324	245	243	161	26	1.2k
Ingalill Avis United States	19	911 1.2×	258 0.8×	203 0.8×	323 1.3×	425 2.6×	42	1.8k
Kristin Austlid Taskén Norway	17	455 0.6×	261 0.8×	74 0.3×	252 1.0×	209 1.3×	34	1.0k
Bayram Edemir Germany	22	715 0.9×	223 0.7×	76 0.3×	128 0.5×	440 2.7×	60	1.6k
Louis McMahon Switzerland	9	666 0.9×	208 0.6×	53 0.2×	277 1.1×	198 1.2×	11	1.1k
James L. Thorne United Kingdom	23	593 0.8×	122 0.4×	213 0.9×	355 1.5×	209 1.3×	45	1.1k
Marjo Malinen Finland	19	555 0.7×	171 0.5×	175 0.7×	158 0.7×	178 1.1×	35	935
Hidenori Kawashima Japan	23	426 0.6×	159 0.5×	126 0.5×	127 0.5×	257 1.6×	59	1.1k
Swneke D. Bailey Canada	20	935 1.2×	98 0.3×	455 1.9×	294 1.2×	153 1.0×	33	1.6k
Elin Thysell Sweden	18	568 0.7×	415 1.3×	52 0.2×	359 1.5×	197 1.2×	38	1.1k
B.N. Díaz-Chico Spain	18	431 0.6×	140 0.4×	318 1.3×	160 0.7×	189 1.2×	63	1.0k

Countries citing papers authored by Bryan M. Wittmann

Since Specialization

Citations

This map shows the geographic impact of Bryan M. Wittmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan M. Wittmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan M. Wittmann more than expected).

Fields of papers citing papers by Bryan M. Wittmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan M. Wittmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan M. Wittmann. The network helps show where Bryan M. Wittmann may publish in the future.

Co-authorship network of co-authors of Bryan M. Wittmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan M. Wittmann. A scholar is included among the top collaborators of Bryan M. Wittmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan M. Wittmann. Bryan M. Wittmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ford, Lisa A., Matthew Mitchell, Jacob Wulff, et al.. (2022). Clinical metabolomics for inborn errors of metabolism. Advances in clinical chemistry. 107. 79–138. 7 indexed citations

Rajasekaran, Surender, Caleb Bupp, Mara L. Leimanis, et al.. (2021). Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease. eLife. 10. 22 indexed citations

Goodman, Kelli D., Matthew Mitchell, Anne M. Evans, et al.. (2021). Assessment of the effects of repeated freeze thawing and extended bench top processing of plasma samples using untargeted metabolomics. Metabolomics. 17(3). 31–31. 13 indexed citations

Kennedy, Adam D., Lisa A. Ford, Bryan M. Wittmann, et al.. (2021). Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives. PLoS ONE. 16(4). e0249797–e0249797. 19 indexed citations

Kennedy, Adam D., Bryan M. Wittmann, Anne M. Evans, et al.. (2018). Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing. Journal of Mass Spectrometry. 53(11). 1 indexed citations

Sahu, Divya, Yair Lotan, Bryan M. Wittmann, Bruce Neri, & Donna E. Hansel. (2016). Abstract 2: Metabolomics analysis reveals distinct profiles of non-muscle invasive and muscle-invasive bladder cancer. Cancer Research. 76(14_Supplement). 2–2. 9 indexed citations

Wittmann, Bryan M., Steven M. Stirdivant, Matthew Mitchell, et al.. (2014). Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine. PLoS ONE. 9(12). e115870–e115870. 100 indexed citations

Song, Kyung, et al.. (2014). HEXIM1 plays a critical role in the inhibition of the androgen receptor by anti-androgens. Biochemical Journal. 462(2). 315–327. 16 indexed citations

Fessel, Joshua P., Rizwan Hamid, Bryan M. Wittmann, et al.. (2012). Metabolomic Analysis of Bone Morphogenetic Protein Receptor Type 2 Mutations in Human Pulmonary Endothelium Reveals Widespread Metabolic Reprogramming. Pulmonary Circulation. 2(2). 201–213. 111 indexed citations

10.

Smith, Kerri M., Tianyi M. Krupka, Bryan M. Wittmann, et al.. (2012). Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene. 32(33). 3829–3839. 29 indexed citations

11.

Frigo, Daniel E., Matthew K. Howe, Bryan M. Wittmann, et al.. (2010). CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells. Cancer Research. 71(2). 528–537. 107 indexed citations

12.

Kobayashi, Sakiko, James P. Stice, Dmitri Kazmin, et al.. (2010). Mechanisms of Progesterone Receptor Inhibition of Inflammatory Responses in Cellular Models of Breast Cancer. Molecular Endocrinology. 24(12). 2292–2302. 30 indexed citations

13.

Kobayashi, Sakiko, James P. Stice, Dmitri Kazmin, et al.. (2010). Mechanisms of Progesterone Receptor Inhibition of Inflammatory Responses in Cellular Models of Breast Cancer. The Journal of Clinical Endocrinology & Metabolism. 95(12). 5457–5457. 2 indexed citations

14.

Norris, John D., Ching‐yi Chang, Bryan M. Wittmann, et al.. (2009). The Homeodomain Protein HOXB13 Regulates the Cellular Response to Androgens. Molecular Cell. 36(3). 405–416. 162 indexed citations

15.

Frigo, Daniel E., Andrea B. Sherk, Bryan M. Wittmann, et al.. (2009). Induction of Krüppel-Like Factor 5 Expression by Androgens Results in Increased CXCR4-Dependent Migration of Prostate Cancer Cellsin Vitro. Molecular Endocrinology. 23(9). 1385–1396. 57 indexed citations

16.

Wittmann, Bryan M., Andrea B. Sherk, & Donald P. McDonnell. (2007). Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators. Cancer Research. 67(19). 9549–9560. 101 indexed citations

17.

Wittmann, Bryan M., Koh Fujinaga, Huayun Deng, Ndiya Ogba, & Monica M. Montano. (2005). The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene. 24(36). 5576–5588. 70 indexed citations

18.

Wittmann, Bryan M., Nancy Wang, & Monica M. Montano. (2003). Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors.. PubMed. 63(16). 5151–8. 56 indexed citations

19.

Montano, Monica M., Bryan M. Wittmann, & Nicole R. Bianco. (2000). Identification and Characterization of a Novel Factor That Regulates Quinone Reductase Gene Transcriptional Activity. Journal of Biological Chemistry. 275(44). 34306–34313. 27 indexed citations

20.

Kissling, Werner, et al.. (1985). Double-blind Comparison of Haloperidol Decanoate and Fluphenazine Decanoate Effectiveness, Side-effects, Dosage and Serum Levels during a Six Months' Treatment for Relapse Prevention. Pharmacopsychiatry. 18(3). 240–245. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact